<DOC>
	<DOC>NCT02592265</DOC>
	<brief_summary>The objective of this study is to measure economic burden of Multiple Sclerosis (MS) from a new point of view that includes consequences of disability on Quality Of Life (QOL), social participation and capabilities of patients and caregivers. To the investigators' knowledge, there is currently no data including intangible costs related to caregivers and calculating the overall economic cost of Multiple Sclerosis, particularly, in France.</brief_summary>
	<brief_title>Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden</brief_title>
	<detailed_description>The goal of this study is to evaluate prospectively the economic burden of Multiple Sclerosis (MS) in France by calculating direct costs (medical and non-medical) and indirect costs and by estimating consequences of MS on utility (QALY) of patients and caregivers in a societal perspective.</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Participant aged 18 or more Confirmed MS diagnosis (McDonald 2005) Defined type of MS according classification of Lublin and Reingold Subject living in an institution Severe cognitive dysfunction preventing to answer questionnaire Subject already included in other clinical study (phase 1 to 3)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>